NCT02939352

Brief Summary

High relapse rates among substance dependent individuals are likely due to a combination of factors that involve limbic circuits in the brain involved in craving, including vulnerability to salient cues. Emerging data suggests that non-invasive, targeted brain stimulation may be able to modulate activity in these circuits and decrease craving. The primary goal of this pilot study is to determine the extent to which a single session of continuous theta burst stimulation to the medial prefrontal cortex can attenuate limbic circuitry involved in craving among cocaine users and alcohol users. This will be tested through a double-blind,sham-controlled brain stimulation and brain imaging study in a cohort of polysubstance abusers and alcohol users.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 28, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
11 months until next milestone

First Posted

Study publicly available on registry

October 20, 2016

Completed
Last Updated

July 23, 2018

Status Verified

July 1, 2018

Enrollment Period

1.2 years

First QC Date

September 28, 2015

Last Update Submit

July 19, 2018

Conditions

Keywords

Transcranial Magnetic StimulationMagnetic Resonance ImagingMRI, Functional

Outcome Measures

Primary Outcomes (1)

  • Percent Blood Oxygen-Level Dependent (BOLD) signal change in the Medial Prefrontal Cortex (MPFC)

    1 hour

Secondary Outcomes (2)

  • Self reported craving

    1 hour

  • Percent Blood Oxygen-Level Dependent (BOLD) signal change in the Striatum

    1 hour

Study Arms (2)

Cocaine Users

EXPERIMENTAL

Participants will receive Real continuous Theta Burst Stimulation to the left frontal pole/medial prefrontal cortex. Participants will also receive Sham continuous Theta Burst Stimulation to the left frontal pole/medial prefrontal cortex.

Device: Real continuous Theta Burst StimulationDevice: Sham continuous Theta Burst Stimulation

Alcohol Users

EXPERIMENTAL

Participants will receive Real continuous Theta Burst Stimulation to the left frontal pole/medial prefrontal cortex. Participants will also receive Sham continuous Theta Burst Stimulation to the left frontal pole/medial prefrontal cortex.

Device: Real continuous Theta Burst StimulationDevice: Sham continuous Theta Burst Stimulation

Interventions

Continuous Theta Burst stimulation delivered

Alcohol UsersCocaine Users

active sham Continuous Theta Burst stimulation delivered

Alcohol UsersCocaine Users

Eligibility Criteria

Age25 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 25-55
  • Non-treatment seeking cocaine users (with or without comorbid alcohol use disorder)
  • Current alcohol use greater than 20 standard drinks per week
  • Current DSM-V Alcohol Use Disorder diagnosis, including the loss of control item
  • Currently not engaged in, and do not want treatment for, alcohol related problems
  • Able to read and understand questionnaires and informed consent
  • Lives within 50 miles of the study site

You may not qualify if:

  • Any current DSM-V Axis I diagnosis except Alcohol, Cocaine, or Nicotine Use Disorder
  • Current or past substance dependence criteria other than cocaine, marijuana, or alcohol, smoking \>1 pack of cigarettes per day
  • Current use of any psychoactive substance except cocaine, nicotine, and marijuana or medications as evidenced by self-report or urine drug screen
  • Current breath alcohol concentration \>0.002
  • Positive urine drug screen for stimulants (including cocaine, amphetamine, methamphetamine, etc.) at the Scanning/Stimulation visits and signs of alcohol withdrawal. Based on the sensitivity of this test, this will require that the participants abstain from cocaine use for 48 hours prior to the intervention
  • History of seizures or migraine headaches
  • History of head trauma or epilepsy
  • Violation of other magnetic resonance imaging safety measures
  • Current suicidal or homicidal ideation
  • Presence of ferrous metal in the body, as evidenced by metal screening and self-report
  • Severe claustrophobia or extreme obesity that preclude placement in the MRI scanner
  • For female participants, pregnancy, as evidenced by a urine pregnancy test administered on the day of the scanning session

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

Related Publications (1)

  • Kearney-Ramos TE, Dowdle LT, Lench DH, Mithoefer OJ, Devries WH, George MS, Anton RF, Hanlon CA. Transdiagnostic Effects of Ventromedial Prefrontal Cortex Transcranial Magnetic Stimulation on Cue Reactivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jul;3(7):599-609. doi: 10.1016/j.bpsc.2018.03.016. Epub 2018 Apr 10.

MeSH Terms

Conditions

AlcoholismCocaine-Related DisordersSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Colleen A Hanlon, PhD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2015

First Posted

October 20, 2016

Study Start

September 1, 2014

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

July 23, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations